Back to Search Start Over

Atacicept Gets Breakthrough Therapy Status for Immunoglobulin A Nephropathy

Authors :
Park, Brian
Source :
MPR Monthly Prescribing Reference. May 29, 2024
Publication Year :
2024

Abstract

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to atacicept for the treatment of immunoglobulin A nephropathy (IgAN). The designation is supported by data from the phase [...]

Subjects

Subjects :
United States. Food and Drug Administration
Immunoglobulin A
Kidney diseases -- Drug therapy
Health

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.795600340

Tools

Authors Abstract Subjects Details